DINOPROSTONE VAGINAL INSERT FOR CERVICAL RIPENING AND LABOR INDUCTION
- 1 May 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 97 (5) , 847-855
Abstract
Objective To compare dinoprostone 10 mg controlled-release vaginal insert with other forms of vaginal or cervical prostaglandin for cervical ripening. Data Sources Literature search strategy included review of the Cochrane database of randomized trials, on-line searching of MEDLINE, hand searching of bibliographies, and contact with authors of relevant reports. Methods of Study Selection Randomized trials were included if they compared a dinoprostone slow-release vaginal insert with an alternative vaginal or cervical prostaglandin for cervical ripening and labor induction in women at term with singleton gestations. Primary end points were delivery by 24 hours postinsertion, uterine hypertonus with fetal heart change, and cesarean delivery rate. Study inclusion, validity assessment, and data extraction were carried out independently by two reviewers, and cross-checked for consistency. Data were combined when appropriate, using the Mantel–Haenszel fixed-effects method. Statistical heterogeneity was assessed using chi-square statistics. Tabulation, Integration, and Results Nine relevant trials were identified, seven comparing the dinoprostone 10 mg vaginal insert with dinoprostone gel and two with misoprostol. Five trials reported adequate methods for randomization concealment. None were double blind. The likelihood of delivery by 24 hours was similar with the vaginal insert and alternatives: common odds ratio (OR) 0.80 (95% confidence interval [CI] 0.56, 1.15). Uterine hypertonus with change in fetal heart and cesarean delivery rate were also similar: common OR 1.19 (95% CI 0.56, 2.54) and 0.78 (95% CI 0.56, 1.08), respectively. The secondary end points of mean time to delivery and delivery by 12 hours appeared to favor misoprostol-dinoprostone gel. However, data for these end points were heterogeneous and their combination is therefore of limited value and potentially misleading. Conclusion No clinically significant differences were identified between the vaginal insert and alternatives used for cervical ripening at term.Keywords
This publication has 10 references indexed in Scilit:
- Pre-eclampsia and induction of labor: A randomized comparison of prostaglandin E2 as an intracervical gel, with oxytocin immediately, or as a sustained-release vaginal insertAmerican Journal of Obstetrics and Gynecology, 1998
- Effectiveness of prostaglandin E2 intracervical gel (Prepidil), with immediate oxytocin, versus vaginal insert (Cervidil) for induction of laborAmerican Journal of Obstetrics and Gynecology, 1998
- A randomized clinical trial of prostaglandin E2 intracervical gel and a slow release vaginal pessary for preinduction cervical ripeningAmerican Journal of Obstetrics and Gynecology, 1998
- Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: A randomized trialObstetrics & Gynecology, 1998
- A comparison of an intravaginal controlled release prostaglandin E2 (10 mg) for cervical ripening and initiation of labour versus prostaglandin E2 vaginal tablet (3 mg)Journal of Obstetrics and Gynaecology, 1998
- Prostaglandin E2 for cervical ripening: A randomized comparison of Cervidil versus PrepidilAmerican Journal of Obstetrics and Gynecology, 1997
- A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor inductionAmerican Journal of Obstetrics and Gynecology, 1997
- A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor inductionAmerican Journal of Obstetrics and Gynecology, 1996
- The Science of Reviewing ResearchaAnnals of the New York Academy of Sciences, 1993
- Patterns of uterine activity after intravaginal prostaglandin E2 during preinduction cervical ripeningAmerican Journal of Obstetrics and Gynecology, 1991